A131030 Stock Overview
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
OPTUS Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,040.00 |
| 52 Week High | ₩9,550.00 |
| 52 Week Low | ₩4,465.00 |
| Beta | 0.47 |
| 1 Month Change | 2.90% |
| 3 Month Change | 16.15% |
| 1 Year Change | 3.78% |
| 3 Year Change | -30.73% |
| 5 Year Change | -39.60% |
| Change since IPO | 13.32% |
Recent News & Updates
There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise
Mar 25
OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality
Mar 13Recent updates
There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise
Mar 25OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality
Mar 13The Returns On Capital At DHP Korea (KOSDAQ:131030) Don't Inspire Confidence
Apr 05DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit
Mar 09DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 10
How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 12Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?
Dec 08Shareholder Returns
| A131030 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 0.7% | 3.0% | -3.3% |
| 1Y | 3.8% | 26.1% | 1.2% |
Return vs Industry: A131030 underperformed the KR Medical Equipment industry which returned 26.1% over the past year.
Return vs Market: A131030 exceeded the KR Market which returned 1.2% over the past year.
Price Volatility
| A131030 volatility | |
|---|---|
| A131030 Average Weekly Movement | 11.1% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A131030's share price has been volatile over the past 3 months.
Volatility Over Time: A131030's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | Dong-Hwa Han | www.optuspharm.com |
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name.
OPTUS Pharmaceutical Co., Ltd. Fundamentals Summary
| A131030 fundamental statistics | |
|---|---|
| Market cap | ₩97.57b |
| Earnings (TTM) | ₩10.76b |
| Revenue (TTM) | ₩72.43b |
9.1x
P/E Ratio1.3x
P/S RatioIs A131030 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A131030 income statement (TTM) | |
|---|---|
| Revenue | ₩72.43b |
| Cost of Revenue | ₩31.07b |
| Gross Profit | ₩41.35b |
| Other Expenses | ₩30.59b |
| Earnings | ₩10.76b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 666.15 |
| Gross Margin | 57.10% |
| Net Profit Margin | 14.86% |
| Debt/Equity Ratio | 0% |
How did A131030 perform over the long term?
See historical performance and comparison